Morningstar Investor users sign in here.

Company Profile

  • Business description

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.

  • Contact

    225 Binney Street
    Cambridge MA 02142
    USA

    T: +1 617 679-2000

    E: IR@biogen.com

    https://www.biogen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    7,570

Biogen Inc News & Analysis

stocks

24 stocks for 2030

Morningstar thinks these companies are well positioned to benefit from one of five key trends during the next decade, writes Susan Dziubinski.
video

3 top picks in global healthcare

American Century Investments' low-turnover strategy invests in companies developing vaccines, treatments for neuro-cognitive diseases and innovations in telemedicine.
video

4 healthcare stocks attractive on valuation and ESG risk

Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,015.80 72.20 0.91%
CAC 40 7,571.57 68.30 0.91%
DAX 40 18,068.21 66.19 0.37%
Dow JONES (US) 38,778.10 188.94 0.49%
FTSE 100 8,142.15 4.71 -0.06%
HKSE 17,890.49 45.63 -0.25%
NASDAQ 17,857.02 168.14 0.95%
Nikkei 225 38,482.11 379.67 1.00%
NZX 50 Index 11,767.40 68.89 0.59%
S&P 500 5,473.23 41.63 0.77%
S&P/ASX 200 7,778.10 77.80 1.01%
SSE Composite Index 3,025.83 9.94 0.33%

Market Movers

Name
Last price
Change
% Change
Fortescue Ltd FMG 21.79 1.19 -5.18%
Melbana Energy Ltd MAY 0.05 0.02 -31.82%
Pilbara Minerals Ltd PLS 3.26 0.12 3.82%
Core Lithium Ltd CXO 0.09 0.00 3.45%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Telstra Group Ltd TLS 3.60 0.05 1.41%
Beach Energy Ltd BPT 1.53 0.04 -2.24%
Imugene Ltd IMU 0.06 0.00 -3.45%
Red 5 Ltd RED 0.45 0.01 -1.10%
South32 Ltd S32 3.64 0.02 0.55%